Low
₹832.40
High
₹859.75
| Previous Close | ₹841.45 |
|---|---|
| Day's Range | ₹832.40 - ₹859.75 |
| Open | ₹846.00 |
| 52 Week Range | ₹577.00 - ₹1,104.30 |
| Volume | 29,82,573 |
| Market Cap | ₹0.06 |
| Trade Value ( ₹ in Lacs) | 25,207.64 |
|---|---|
| Market Cap (₹ in Mn) | 0.06 |
| Dividend Yield(%) | 0.12 |
| Price/Earning (TTM) | 62.64 |
| TTM EPS (₹) | 13.43 |
| P/E Ratio | 68.11 |
| Book Value(₹) | 6.74 |
| PAT Margin (%) | 10.40 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 12.14 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 19883.9 | 68929.2 |
| Expenses | N/A | N/A |
| PBT | 2610.5 | 8579.7 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1930.8 | 6452.2 |
| Founded | 1996 |
|---|---|
| Managing Director | Ashutosh Raghuvanshi |
| NSE Symbol | FORTIS |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 3,92,147.31 | 1,634.20 | 1,547.25 - 1,850.95 |
| Divi's Laboratories Ltd. | 1,61,208.45 | 6,071.00 | 4,941.70 - 7,077.70 |
| Torrent Pharmaceuticals Ltd. | 1,36,190.45 | 4,020.50 | 2,891.45 - 4,124.95 |
| Cipla Ltd. | 1,10,789.94 | 1,370.40 | 1,310.05 - 1,672.20 |
| Dr. Reddy's Laboratories Ltd. | 1,01,587.03 | 1,217.50 | 1,025.90 - 1,377.95 |
| Lupin Ltd. | 98,899.23 | 2,163.20 | 1,774.00 - 2,228.35 |
| Apollo Hospitals Enterprise Ltd. | 97,730.43 | 6,797.00 | 6,002.15 - 8,099.00 |
| Max Healthcare Institute Ltd. | 97,202.85 | 998.80 | 940.35 - 1,314.30 |
| Zydus Lifesciences Ltd. | 89,036.61 | 885.30 | 797.05 - 1,059.00 |
| Mankind Pharma Ltd. | 88,662.27 | 2,147.00 | 2,081.80 - 2,726.75 |
Posted on Jan 22nd
Futuristic Solutions informs about updates
Posted on Jan 22nd
NFP Sampoorna Foods coming with IPO to raise Rs 24.53 crore
Posted on Jan 22nd
Currency futures for January expiry trade stronger with 1.31% increase in OI
Posted on Jan 22nd
India to become world's third-largest economy over next few years: Ashwini Vaishnaw
The current share price of Fortis Healthcare Ltd. is ₹841.45 as of 2026-01-22.
The market capitalisation of Fortis Healthcare Ltd. is ₹63,514.63 as of 2026-01-22.
The 1-year return of Fortis Healthcare Ltd. is 0.00% as of 2026-01-22.
The P/E ratio of Fortis Healthcare Ltd. is 68.11 as of 2026-01-23.
The 52-week high and low of Fortis Healthcare Ltd. are ₹1,104.30 and ₹577.00, respectively, as of 2026-01-22.
Fortis Healthcare Ltd. operates a network of healthcare facilities across India and select international markets, with over 4,000 operational beds, as per company disclosures. Its services include multispecialty acute care, organ transplantation, cardiac care, oncology, neurosciences, orthopaedics, and fertility treatment. The company also operates diagnostic centres offering imaging and pathology services.
Fortis Healthcare has expanded its healthcare and diagnostics presence through acquisitions and strategic investments, as disclosed by the company. These include acquisitions in hospital operations and a minority stake in a diagnostics platform to support service integration. Fortis is majority-owned by IHH Healthcare Berhad, providing linkage to an international healthcare group, as per public disclosures.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.